Stewart Kroll

Person

South San Francisco, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Treatment of cancer using hypoxia activated prodrugs
- Patent number 8,946,275
- Issue date Feb 3, 2015
- Threshold Pharmaceuticals, Inc.
- John G. Curd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer with glufosfamide in patients not receiving ins...
- Patent number 8,765,690
- Issue date Jul 1, 2014
- Threshold Pharmaceuticals, Inc.
- Damian Handisides
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Patient-specific dosimetry
- Patent number 7,668,662
- Issue date Feb 23, 2010
- The Regents of the University of Michigan
- Stewart M. Kroll
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Administration of hypoxia activated prodrugs and antiangiogenic age...
- Publication number 20190060275
- Publication date Feb 28, 2019
- Molecular Templates, Inc.
- Charles Hart
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER
- Publication number 20170232017
- Publication date Aug 17, 2017
- Threshold Pharmaceuticals, Inc.
- Stewart Kroll
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of Cancer
- Publication number 20160045522
- Publication date Feb 18, 2016
- Threshold Pharmaceuticals, Inc.
- Stewart Kroll
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of Cancer with Glufosfamide in Patients Not Receiving Ins...
- Publication number 20150272973
- Publication date Oct 1, 2015
- Threshold Pharmaceuticals, Inc.
- Damian Handisides
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER USING HYPOXIA ACTIVATED PRODRUGS
- Publication number 20150258125
- Publication date Sep 17, 2015
- THRESHOLD PHARMACEUTICALS, INC.
- John G. Curd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
UNIT DOSE FORM FOR ORAL ADMINISTRATION
- Publication number 20140072624
- Publication date Mar 13, 2014
- Threshold Pharmaceuticals, Inc.
- Donald Jung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ADMINISTRATION OF HYPOXIA ACTIVATED PRODRUGS AND ANTIANGIOGENIC AGE...
- Publication number 20140010805
- Publication date Jan 9, 2014
- Charles Hart
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF BLOOD CANCER
- Publication number 20130296273
- Publication date Nov 7, 2013
- THRESHOLD PHARMACEUTICALS, INC.
- John Curd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of Cancer Using Hypoxia Activated Prodrugs
- Publication number 20130202716
- Publication date Aug 8, 2013
- John G. Curd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLUFOSFAMIDE COMBINATION THERAPY
- Publication number 20100104549
- Publication date Apr 29, 2010
- Threshold Pharmaceuticals, Inc.
- Damian Handisides
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Patient-specific dosimetry
- Publication number 20050288869
- Publication date Dec 29, 2005
- SmithKline Beecham Corporation
- Stewart M. Kroll
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Stewart Kroll

Person

Patents Grantslast 30 patents

Treatment of cancer using hypoxia activated prodrugs

Treatment of cancer with glufosfamide in patients not receiving ins...

Patient-specific dosimetry

Patents Applicationslast 30 patents

Administration of hypoxia activated prodrugs and antiangiogenic age...

TREATMENT OF CANCER

Treatment of Cancer

Treatment of Cancer with Glufosfamide in Patients Not Receiving Ins...

TREATMENT OF CANCER USING HYPOXIA ACTIVATED PRODRUGS

UNIT DOSE FORM FOR ORAL ADMINISTRATION

ADMINISTRATION OF HYPOXIA ACTIVATED PRODRUGS AND ANTIANGIOGENIC AGE...

TREATMENT OF BLOOD CANCER

Treatment of Cancer Using Hypoxia Activated Prodrugs

GLUFOSFAMIDE COMBINATION THERAPY

Patient-specific dosimetry